264 related articles for article (PubMed ID: 30077492)
1. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
Rodrigues PP; Ferreira-Santos D; Silva A; Polónia J; Ribeiro-Vaz I
Artif Intell Med; 2018 Sep; 91():12-22. PubMed ID: 30077492
[TBL] [Abstract][Full Text] [Related]
2. A tailor-made approach for causality assessment for ADR reports on drugs and vaccines.
Oosterhuis I; Zweers P; Rümke H; Muller-Hansma A; van Puijenbroek EP
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):544-550. PubMed ID: 30168222
[TBL] [Abstract][Full Text] [Related]
3. Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations.
Ribeiro A; Lima S; Zampieri ME; Peinado M; Figueras A
Expert Opin Drug Saf; 2017 Dec; 16(12):1329-1334. PubMed ID: 28817316
[TBL] [Abstract][Full Text] [Related]
4. Leveraging Machine Learning to Facilitate Individual Case Causality Assessment of Adverse Drug Reactions.
Cherkas Y; Ide J; van Stekelenborg J
Drug Saf; 2022 May; 45(5):571-582. PubMed ID: 35579819
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre.
Théophile H; Arimone Y; Miremont-Salamé G; Moore N; Fourrier-Réglat A; Haramburu F; Bégaud B
Drug Saf; 2010 Nov; 33(11):1045-54. PubMed ID: 20925441
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different methods for causality assessment of adverse drug reactions.
Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
[TBL] [Abstract][Full Text] [Related]
7. Toward Kidney-Specific Causality Assessment Tool.
Kaya M; Duru M; Gulmez SE
Clin Ther; 2022 Jul; 44(7):e59-e75. PubMed ID: 35725506
[TBL] [Abstract][Full Text] [Related]
8. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
[TBL] [Abstract][Full Text] [Related]
9. Causality assessment in pharmacovigilance: The French method and its successive updates.
Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
[TBL] [Abstract][Full Text] [Related]
10. Preliminary Results of a Novel Algorithmic Method Aiming to Support Initial Causality Assessment of Routine Pharmacovigilance Case Reports for Medication-Induced Liver Injury: The PV-RUCAM.
Scalfaro E; Streefkerk HJ; Merz M; Meier C; Lewis D
Drug Saf; 2017 Aug; 40(8):715-727. PubMed ID: 28508325
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database.
Berbain T; Pariente A; Miremont-Salamé G; Grandvuillemin A; Micallef J; Chouchana L; Benkebil M; Théophile H;
Drug Saf; 2020 Mar; 43(3):243-253. PubMed ID: 31974775
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
13. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System.
Kreimeyer K; Dang O; Spiker J; Muñoz MA; Rosner G; Ball R; Botsis T
Comput Biol Med; 2021 Aug; 135():104517. PubMed ID: 34130003
[TBL] [Abstract][Full Text] [Related]
14. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
[TBL] [Abstract][Full Text] [Related]
15. First experiences with a tool to measure the level of clinical information present in adverse drug reaction reports.
Oosterhuis I; Rolfes L; Ekhart C; Muller-Hansma A; Härmark L
Expert Opin Drug Saf; 2018 Feb; 17(2):111-115. PubMed ID: 29157026
[TBL] [Abstract][Full Text] [Related]
16. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions.
Jarernsiripornkul N; Chaipichit N; Pratipanawatr T; Uchaipichat V; Krska J
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):54-63. PubMed ID: 26349635
[TBL] [Abstract][Full Text] [Related]
17. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
18. Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.
Durrieu G; Jacquot J; Mège M; Bondon-Guitton E; Rousseau V; Montastruc F; Montastruc JL
Drug Saf; 2016 Dec; 39(12):1189-1195. PubMed ID: 27688025
[TBL] [Abstract][Full Text] [Related]
19. Timeline representation of clinical data: usability and added value for pharmacovigilance.
Ledieu T; Bouzillé G; Thiessard F; Berquet K; Van Hille P; Renault E; Polard E; Cuggia M
BMC Med Inform Decis Mak; 2018 Oct; 18(1):86. PubMed ID: 30340483
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three methods (an updated logistic probabilistic method, the Naranjo and Liverpool algorithms) for the evaluation of routine pharmacovigilance case reports using consensual expert judgement as reference.
Théophile H; André M; Miremont-Salamé G; Arimone Y; Bégaud B
Drug Saf; 2013 Oct; 36(10):1033-44. PubMed ID: 23828659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
